
Jaime R. Merchán, MD, discusses the future treatment of patients with advanced renal cell carcinoma.

Your AI-Trained Oncology Knowledge Connection!


Jaime R. Merchán, MD, discusses the future treatment of patients with advanced renal cell carcinoma.

Jaime R. Merchán, MD, discusses the current roles for immunotherapy and TKIs in patients with renal cell carcinoma.

Jaime R. Merchán, MD, discusses the role of pembrolizumab plus axitinib or lenvatinib in previously untreated advanced renal cell carcinoma.